Martin John Stoermer

Hivatkozott rá

	Összes	2019 óta
Hivatkozások	2939	1045
h-index	25	17
i10-index	37	21

220

110

165

199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320249 17 26 12 13 11 15 18 18 45 75 87 84 114 157 102 139 159 127 128 143 170 187 184 214 198 176 150 122

Nyilvános hozzáférés

Összes megtekintése

13 cikk

1 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

David P FairlieProfessor, University of QueenslandE-mail megerősítve itt: imb.uq.edu.au
Paul YoungProfessor of Virology, University of QueenslandE-mail megerősítve itt: uq.edu.au
Robert ReidThe University of Queensland, Institute for Molecular BioscienceE-mail megerősítve itt: imb.uq.edu.au
Andrew J. LuckeThe University of QueenslandE-mail megerősítve itt: uq.edu.au
Jennifer L MartinProfessorE-mail megerősítve itt: griffith.edu.au
Joel TyndallUniversity of OtagoE-mail megerősítve itt: otago.ac.nz
Daniel S. NielsenCenter for Evolutionary Chemical Biology, Department of Chemistry, University of Copenhagen, DenmarkE-mail megerősítve itt: chem.ku.dk
Rink-Jan Lohman PhD, RACTRA,the University of Queensland. PharmEthos ConsultancyE-mail megerősítve itt: uq.edu.au
Junxian LimUniversity of Queensland, Institute for Molecular BioscienceE-mail megerősítve itt: uq.edu.au
Bostjan KobeProfessor of Structural Biology, The University of QueenslandE-mail megerősítve itt: uq.edu.au
Jacky Y SuenCritical Care Research Group, Institute for Molecular Biosciences, UQ/Prince Charles HospitalE-mail megerősítve itt: uq.edu.au
Professor Kate SchroderClarivate Highly Cited Researcher; Lab Head, Institute for Molecular Bioscience, University of QLDE-mail megerősítve itt: imb.uq.edu.au
Ragothaman M. YennamalliSenior Assistant Professor, SASTRA Deemed to be University, IndiaE-mail megerősítve itt: scbt.sastra.ac.in
Lynette BeattieUniversity of MelbourneE-mail megerősítve itt: unimelb.edu.au
Tina Skinner-AdamsResearch Leader, Griffith UniversityE-mail megerősítve itt: griffith.edu.au
Katherine AndrewsGriffith University; Griffith Institute for Drug DiscoveryE-mail megerősítve itt: griffith.edu.au
Ligong LiuGrand Medical Pty LtdE-mail megerősítve itt: grandpharma.cn
Christine E. WrightAssociate Professor, University of MelbourneE-mail megerősítve itt: unimelb.edu.au
Trent M. WoodruffProfessor, The University of QueenslandE-mail megerősítve itt: uq.edu.au
James A ANGUSProfessor of Pharmacology, University of MelbourneE-mail megerősítve itt: unimelb.edu.au

Követés

Martin John Stoermer

University of Queensland

E-mail megerősítve itt: imb.uq.edu.au - Kezdőlap

Medicinal and Organic Chemistry Flaviviruses Coronaviruses Viral proteases


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors D Leung, K Schroder, H White, NX Fang, MJ Stoermer, G Abbenante, ... Journal of Biological Chemistry 276 (49), 45762-45771, 2001	414	2001
Orally absorbed cyclic peptides DS Nielsen, NE Shepherd, W Xu, AJ Lucke, MJ Stoermer, DP Fairlie Chemical reviews 117 (12), 8094-8128, 2017	390	2017
Flavones are inhibitors of HIV-1 proteinase RI Brinkworth, MJ Stoermer, DP Fairlie Biochemical and biophysical research communications 188 (2), 631-637, 1992	192	1992
Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation G Robin, K Chappell, MJ Stoermer, SH Hu, PR Young, DP Fairlie, ... Journal of molecular biology 385 (5), 1568-1577, 2009	172	2009
Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria KT Andrews, DP Fairlie, PK Madala, J Ray, DM Wyatt, PM Hilton, ... Antimicrobial agents and chemotherapy 50 (2), 639-648, 2006	169	2006
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity DR March, LM Proctor, MJ Stoermer, R Sbaglia, G Abbenante, RC Reid, ... Molecular pharmacology 65 (4), 868-879, 2004	142	2004
Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease TA Nall, KJ Chappell, MJ Stoermer, NX Fang, JDA Tyndall, PR Young, ... Journal of Biological Chemistry 279 (47), 48535-48542, 2004	140	2004
In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses T Kampmann, R Yennamalli, P Campbell, MJ Stoermer, DP Fairlie, ... Antiviral research 84 (3), 234-241, 2009	134	2009
West Nile Virus NS2B/NS3 protease as an antiviral target KJ Chappell, MJ Stoermer, DP Fairlie, PR Young Current medicinal chemistry 15 (27), 2771-2784, 2008	110	2008
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity MJ Stoermer, KJ Chappell, S Liebscher, CM Jensen, CH Gan, PK Gupta, ... Journal of medicinal chemistry 51 (18), 5714-5721, 2008	96	2008
Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies KJ Chappell, MJ Stoermer, DP Fairlie, PR Young Journal of Biological Chemistry 281 (50), 38448-38458, 2006	95	2006
Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity KJ Chappell, MJ Stoermer, DP Fairlie, PR Young Journal of general virology 89 (4), 1010-1014, 2008	81	2008
Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions KJ Chappell, TA Nall, MJ Stoermer, NX Fang, JDA Tyndall, DP Fairlie, ... Journal of Biological Chemistry 280 (4), 2896-2903, 2005	75	2005
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed TA Hill, RJ Lohman, HN Hoang, DS Nielsen, CCG Scully, WM Kok, L Liu, ... ACS medicinal chemistry letters 5 (10), 1148-1151, 2014	72	2014
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists V Seow, J Lim, AJ Cotterell, MK Yau, W Xu, RJ Lohman, WM Kok, ... Scientific reports 6 (1), 24575, 2016	48	2016
Current status of virtual screening as analysed by target class MJ Stoermer Medicinal Chemistry 2 (1), 89-112, 2006	47	2006
Structural Mimicry of Two Cytochrome b₅₆₂ Interhelical Loops Using Macrocycles Constrained by Oxazoles and Thiazoles Y Singh, MJ Stoermer, AJ Lucke, T Guthrie, DP Fairlie Journal of the American Chemical Society 127 (18), 6563-6572, 2005	44	2005
Vinyl Cation Formation by Decomposition of Vinyl-lead Triacetates. The reactions of Vinylmercury and Vinyltin Compounds with Lead Tetraacetate MG Moloney, JT Pinhey, MJ Stoermer Journal of the Chemical Society, Perkin Transactions 1 10, 2645, 1990	43	1990
Downsizing a human inflammatory protein to a small molecule with equal potency and functionality RC Reid, MK Yau, R Singh, JK Hamidon, AN Reed, P Chu, JY Suen, ... Nature communications 4 (1), 2802, 2013	41	2013
Regioselective synthesis of antiparallel loops on a macrocyclic scaffold constrained by oxazoles and thiazoles Y Singh, MJ Stoermer, AJ Lucke, MP Glenn, DP Fairlie Organic Letters 4 (20), 3367-3370, 2002	33	2002

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők